TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
AURA

Aura Biosciences Inc

Healthcare · Biotechnology

6.20$ +2.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AURA
Line item 2019 2020 2021 2022 2023 2024 2025
– -40.3% +624.0% +39.9% +13.9% -28.5% -7.2%
– -44.7% +732.9% +28.0% +17.8% -30.7% -6.8%
– -46.4% +757.0% -18.4% -66.2% -22.8% +87.8%
– -46.4% +757.0% +26.7% +19.8% -33.2% -4.5%
– -1.7% +46.9% +2.3% – – –
– -56.4% +181.5% +267.5% +3.1% +4.5% +6.5%
– -56.7% +176.4% +42.2% +18.2% +20.7% +23.3%
– – +4,000.0% +381.8% -9.3% +17.2% +3.0%
– -73.8% +293.0% +21.7% -38.8% +28.9% -32.8%
– – – – – – –
– -37.1% +686.6% +28.4% +15.5% -32.7% -9.9%
– – – – – – –
– -99.0% 0.0% +2.5% +32.3% +25.3% +21.5%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?